Key facts
- It has raised $44.8M; the latest was Later Stage VC ($20.0M) in Jan 2025.
- Notable investors include Innovate UK, Tech Nation Group, Scottish Enterprise, Novo Holdings, Future Planet Capital — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Roslin Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Roslin Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Roslin Technologies
Developer of animal stem cell technology designed to support the production of cultivated meat and advance applications in animal health and cultivated tissue. The company offers high-performance, scalable, and licensable cell lines, enabling cultivated meat producers and food companies to reduce costs and accelerate product development.
- Sector
- Healthcare
- HQ
- Edinburgh, United Kingdom
- Founded
- 2016
- Employees
- 26
- Website
- roslintech.com/
- Ownership
- Privately Held (backing)
Roslin Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Roslin Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Roslin Technologies in its N-PORT filings yet. We sweep new filings monthly.